Stable Angina
📧 Sign up to get email alerts when something new happens for Stable Angina.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: CORonary MICrovascular Angina (CorMicA) [NA]
Clinical trial CorMICA assessing stable angina, microvascular angina, and coronary vasospasm has completed.
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters
A prospective registry study comparing sirolimus-eluting and paclitaxel-eluting balloon catheters in coronary artery disease patients; the s…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease
A prospective registry study (COMPLEX Registry) enrolling patients with complex and calcified coronary artery disease. The goal is to descri…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Performance of the Acoustic Based CADScor System in Coronary Artery Disease
This clinical trial update describes the planned performance assessment of the acoustic CADScor System in coronary artery disease, with recr…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
This clinical trial update examines contrast-associated acute kidney injury across different types of coronary artery disease, and the study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2024-08-13FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MATZIM LA (diltiazem hydrochloride) from Actavis Pharma, Inc. to update labeling for this long-a…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Intracoronary Thrombus Detection by Magnetic Resonance Imaging [NA]
This clinical trial evaluated intracoronary thrombus detection using magnetic resonance imaging in patients with angina (stable/unstable) an…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study
The V-GOOD study evaluated the effectiveness and tolerability of trimetazidine 80 mg once daily in patients with chronic coronary syndrome a…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease
Clinical trial investigating how air quality affects the development and progression of premature coronary artery disease; currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease [Phase 4]
Phase 4 completed trial comparing edoxaban alone to edoxaban with an antiplatelet agent in patients with atrial fibrillation and chronic sta…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations [NA]
Clinical trial evaluating diagnostic examinations in patients with stable angina has been terminated; results posted.
-
FDA approval · 2023-05-09FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic Metoprolol Succinate product from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients [Phase 2]
Phase 2 trial comparing ALX-0081 to a GPIIb/IIIa inhibitor in high-risk PCI patients has completed.
-
CLINICAL_TRIALS withdrawal · 2023-03-13Clinical Trial Update: Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries [Phase 4]
Phase 4 trial evaluating ranolazine for myocardial ischemia in patients with chronic total occlusions was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial [Phase 4]
Phase 4 trial assessing strategies for treating coronary artery stenosis using next-generation drug-eluting stents and abbreviated dual anti…
-
FDA approval · 2022-03-29FDA Approved: NIFEDIPINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' Original Application for nifedipine, a calcium channel blocker used to treat hypertension and angina.
-
CLINICAL_TRIALS trial_result · 2021-04-22Clinical Trial Update: Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina [NA]
A completed randomized trial comparing angioplasty with optimal medical therapy in stable angina; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome [Phase 2]
Phase 2 clinical trial update for BuqitongluO Granule targeting qi deficiency and blood stasis syndrome in ischemic stroke and related cardi…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina [Phase 4]
Phase 4 trial comparing amlodipine to nitrates in patients with chronic stable angina has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris [Phase 4]
Phase 4 trial update evaluating efficacy and safety of Xueshuanxinmaining Tablet for stable angina in coronary heart disease.
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery [Phase 3]
Phase 3 clinical trial assessing the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass graf…
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome [Phase 4]
Phase 4 trial evaluating the effect of ranolazine on blood markers in women with stable angina and metabolic syndrome; study completed with …
-
CLINICAL_TRIALS research · 2020-02-25Clinical Trial Update: Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases
A completed correlational study evaluating biomarker applications for predicting and diagnosing cardiovascular diseases, specifically focusi…
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)
A completed clinical trial exploring downstream molecular signals of P2Y12 receptors in patients with high on-treatment platelet reactivity …
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina [Phase 4]
Phase 4 trial update evaluating testosterone therapy effects on angina threshold and atheroma in patients with chronic stable angina.